Abstract

RANK ligand (RANKL) induces activation of NFkappaB, enhancing the formation, resorptive activity, and survival of osteoclasts. Ca(2+) transduces many signaling events, however, it is not known whether the actions of RANKL involve Ca(2+) signaling. We investigated the effects of RANKL on rat osteoclasts using microspectrofluorimetry and patch clamp. RANKL induced transient elevation of cytosolic free Ca(2+) concentration ([Ca(2+)](i)) to maxima 220 nm above basal, resulting in activation of Ca(2+)-dependent K(+) current. RANKL elevated [Ca(2+)](i) in Ca(2+)-containing and Ca(2+)-free media, and responses were prevented by the phospholipase C inhibitor. Suppression of [Ca(2+)](i) elevation using the intracellular Ca(2+) chelator 1,2-bis(O-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) abolished the ability of RANKL to enhance osteoclast survival. Using immunofluorescence, NFkappaB was found predominantly in the cytosol of untreated osteoclasts. RANKL induced transient translocation of NFkappaB to the nuclei, which was maximal at 15 min. or BAPTA delayed nuclear translocation of NFkappaB. Delays were also observed upon inhibition of calcineurin or protein kinase C. We conclude that RANKL acts through phospholipase C to release Ca(2+) from intracellular stores, accelerating nuclear translocation of NFkappaB and promoting osteoclast survival. Such cross-talk between NFkappaB and Ca(2+) signaling provides a novel mechanism for the temporal regulation of gene expression in osteoclasts and other cell types.

Highlights

  • RANK1 ligand (RANKL) is a member of the tumor necrosis factor superfamily that plays an essential role in osteoclasto

  • Multiple [Ca2ϩ]i transients could be elicited by successive applications of RANK ligand (RANKL) (Fig. 1B), the subsequent responses were slightly decreased in amplitude

  • Using loading conditions established above, we found that BAPTA delayed nuclear translocation of NF␬B induced by RANKL (Fig. 6, data based on parallel samples from seven independent experiments)

Read more

Summary

Introduction

RANK1 ligand (RANKL) is a member of the tumor necrosis factor superfamily that plays an essential role in osteoclasto-. We tested the hypothesis that RANKL signaling in osteoclasts involves elevation of [Ca2ϩ]i, and examined the role of cytosolic Ca2ϩ in cell survival and activation of NF␬B. Effect of PLC Inhibitor on RANKL-induced Nuclear Translocation of NF␬B—NF␬B is one of the major downstream effectors of RANK signaling and activation of NF␬B enhances cell survival in many cell types [13, 26].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call